title: Genetic modifiers of non-alcoholic fatty liver disease progression.
abstract: Non-alcoholic fatty liver disease (NAFLD) is now recognised as the most common cause of liver dysfunction worldwide. However, whilst the majority of individuals who exhibit features of the metabolic syndrome including obesity and insulin resistance will develop steatosis, only a minority progress to steatohepatitis, fibrosis and cirrhosis. Subtle inter-patient genetic variations and environment interact to determine disease phenotype and influence progression. A decade after the sequencing of the human genome, the comprehensive study of genomic variation offers new insights into the modifier genes, pathogenic mechanisms and is beginning to suggest novel therapeutic targets. We review the current status of the field with particular focus on advances from recent genome-wide association studies.
authors.affiliation: Liver Research Group, Instiutte of Cellular Medicine, Teh Medical School, Newcastle University, Framlington Place, Newcaltle-upon-Type, NE2 4HHK, UK.
authors.forename: Quentin M
authors.initials: QM
authors.lastname: Anstee
authors.forename: Ann K
authors.initials: AK
authors.lastname: Daly
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Day
mesh_terms: D000818:Animals; D018450:Disease Progression; D005234:Fatty Liver / Q000209:etiology*; D005796:Genes / Q000502:physiology*; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease; D010641:Phenotype